SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-027433
Filing Date
2018-11-06
Accepted
2018-11-06 16:18:03
Documents
51
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 Q3'18 10-Q fprx-10q_20180930.htm 10-Q 1728885
2 EX-31.1 fprx-ex311_9.htm EX-31.1 8496
3 EX-31.2 fprx-ex312_7.htm EX-31.2 8497
4 EX-32.1 fprx-ex321_8.htm EX-32.1 5342
5 EX-32.2 fprx-ex322_6.htm EX-32.2 5216
6 GRAPHIC gp2q1cnbrkbo000001.jpg GRAPHIC 46838
  Complete submission text file 0001564590-18-027433.txt   6564769

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT fprx-20180930.xml EX-101.INS 1632488
8 XBRL TAXONOMY EXTENSION SCHEMA fprx-20180930.xsd EX-101.SCH 37957
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fprx-20180930_cal.xml EX-101.CAL 38531
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fprx-20180930_def.xml EX-101.DEF 132324
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fprx-20180930_lab.xml EX-101.LAB 296510
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fprx-20180930_pre.xml EX-101.PRE 247852
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36070 | Film No.: 181163220
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1